Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genenta Science S.p.A. - American Depositary Shares (NQ: GNTA ) 4.080 -0.020 (-0.49%) Streaming Delayed Price Updated: 1:36 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Genenta Science S.p.A. - American Depositary Shares < Previous 1 2 Next > 7 Penny Biotech Stocks to Triple Your Investment May 28, 2024 Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. Via InvestorPlace Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider May 06, 2024 From GENENTA SCIENCE SPA Via GlobeNewswire Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference March 01, 2024 Via Investor Brand Network This Small Cap Cancer Company 'Hijacks Tumors From Within," HC Wainwright Says July 25, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 12, 2024 Via Benzinga Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors February 08, 2024 Based on Preliminary Data from Ongoing Dose Ranging Stage of the Phase 1/2 Clinical Trial From GENENTA SCIENCE SPA Via GlobeNewswire Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 22, 2023 Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Via Benzinga Genenta to Present at Upcoming Scientific and Investor Conferences September 06, 2023 From GENENTA SCIENCE SPA Via GlobeNewswire Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments July 28, 2023 Company Selects Refractory Advanced Genitourinary Malignancies including Renal Cell Cancer as Second Indication From GENENTA SCIENCE SPA Via GlobeNewswire The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma June 29, 2023 From GENENTA SCIENCE SPA Via GlobeNewswire Genenta to Provide Update on Lead Product Temferon™ May 16, 2023 Prof. Luigi Naldini will present updates on the efficacy of Temferon in pre-clinical solid tumor models and preliminary clinical biological data confirming in patients From GENENTA SCIENCE SPA Via GlobeNewswire Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing April 26, 2023 From GENENTA SCIENCE SPA Via GlobeNewswire Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 35th Annual Roth Conference February 22, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Tuesday's After-Market Session February 14, 2023 Via Benzinga Genenta Sciences (NASDAQ: GNTA) Featured in Virtual Coverage of Roth’s Healthcare Opportunities Conference September 29, 2022 Via Investor Brand Network 12 Health Care Stocks Moving In Friday's Intraday Session September 16, 2022 Via Benzinga Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session September 12, 2022 Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 January 05, 2023 Via Benzinga Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022 July 25, 2022 Upgrades Via Benzinga Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday September 09, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 28, 2022 Gainers Via Benzinga Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session September 08, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. Via Benzinga Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session June 28, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday June 29, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 23, 2022 Via Benzinga 53 Biggest Movers From Yesterday March 30, 2022 Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... Via Benzinga Genenta Science (NASDAQ: GNTA) Featured in Virtual Coverage of the 34th Annual Roth Conference March 07, 2022 Via Investor Brand Network 12 Health Care Stocks Moving In Thursday's Intraday Session March 03, 2022 Gainers Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 49.1% to $0.28 during Thursday's regular session. As of 12:31 EST, Tonix Pharmaceuticals's stock is trading... Via Benzinga Stocks That Hit 52-Week Lows On Friday February 25, 2022 During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.